
Supplements and Featured Publications
- Therapeutic Updates in Neuroendocrine Tumors
- Volume 1
- Issue 1
Dr. Kennecke on Suggested Multidisciplinary Actions for GEP-NETs
Hagen F. Kennecke, MD, MHA, FRCPC, discusses multidisciplinary interactions within Virginia Mason Medical Center for patients with gastroenteropancreatic neuroendocrine tumors.
Hagen F. Kennecke, MD, MHA, FRCPC, a medical oncologist at Virginia Mason Medical Center, discusses multidisciplinary interactions within Virginia Mason Medical Center for patients with gastroenteropancreatic neuroendocrine tumors.
At a weekly tumor board, Kennecke will present a patient’s history, provide their background, and sequentially review pathology. Pathology must be analyzed to ensure the tumor grade is assessed with Ki-67 differentiation. After, imaging is conducted and repeat imaging is ordered if multi-phase CT scans are not completed, says Kennecke.
Then, the Gallium-68 dotatate (Netspot) PET/CT scan is reviewed and a Krenning score is assigned to all patients, grading to tumors from 0 to 4, according to Kennecke. From this evaluation of the patient, the tumor board decides what the best strategy is before discussing with the patients, he concludes.
Articles in this issue
over 5 years ago
Treatment Selection, Sequencing, and, Unmet Needs in GEP-NETsover 5 years ago
Expert Explains Latest Treatment Strategies in GEP-NETsalmost 6 years ago
Dr. Hope on Sequencing Considerations for GEP-NETsalmost 6 years ago
Dr. Hope on Treatment Options for GEP-NETsalmost 6 years ago
Dr. Kennecke on Available Treatments for GEP-NETsalmost 6 years ago
Dr. Chauhan on Sequencing Therapies for GEP-NETsalmost 6 years ago
Dr. Chauhan on the Role of Somatostatin Analogs Treating GEP-NETs


































